Affluent Medical announces several key appointments for Medical and Clinical affairs. Appointment of Dr. Howard C. Herrmann as strategic Chief Medical Officer for structural heart platform.

Background: There are insufficient data regarding how to deal with moderate aortic valve (AV) dysfunction during rheumatic mitral valve (MV) surgery. In this study, the clinical outcomes of patients ...

The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in ...

The following is a summary of "Tissue-tracking mitral annular displacement predicts impaired left ventricular mechanics and ...

More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the American Heart Association ...

BACKGROUND: Catheter ablation of ventricular arrhythmias, one of the most rapidly growing procedures in cardiac electrophysiology, is associated with magnetic resonance imaging–detected brain lesions ...

Protecting your heart starts with understanding how it works. Heart valve diseases are conditions that can disrupt the flow ...

J.P., a 37-year-old woman ... On June 10 a Starr–Edwards mitral-valve prosthesis was inserted during cardiopulmonary bypass. The mitral valve was approximately 0.5 square centimeter in diameter ...

Recently appointed CEO of Artedrone, the first autonomous robotic solution for Mechanical Thrombectomy, Liane Teplitsky is a successful seasoned senior executive in the medical device with ...

“Heart valve disease often goes undetected until it becomes serious, but early diagnosis can make all the difference,” said Marc Ruel, M.D., M.P.H., FAHA, American Heart Association ...